574 related articles for article (PubMed ID: 31301176)
1. Should cell-free DNA testing be used in pregnancy with increased fetal nuchal translucency?
Miranda J; Paz Y Miño F; Borobio V; Badenas C; Rodriguez-Revenga L; Pauta M; Borrell A
Ultrasound Obstet Gynecol; 2020 May; 55(5):645-651. PubMed ID: 31301176
[TBL] [Abstract][Full Text] [Related]
2. Microarray and RASopathy-disorder testing in fetuses with increased nuchal translucency.
Sinajon P; Chitayat D; Roifman M; Wasim S; Carmona S; Ryan G; Noor A; Kolomietz E; Chong K
Ultrasound Obstet Gynecol; 2020 Mar; 55(3):383-390. PubMed ID: 31115076
[TBL] [Abstract][Full Text] [Related]
3. State-wide utilization and performance of traditional and cell-free DNA-based prenatal testing pathways: the Victorian Perinatal Record Linkage (PeRL) study.
Lindquist A; Hui L; Poulton A; Kluckow E; Hutchinson B; Pertile MD; Bonacquisto L; Gugasyan L; Kulkarni A; Harraway J; Howden A; McCoy R; Da Silva Costa F; Menezes M; Palma-Dias R; Nisbet D; Martin N; Bethune M; Poulakis Z; Halliday J
Ultrasound Obstet Gynecol; 2020 Aug; 56(2):215-224. PubMed ID: 31625225
[TBL] [Abstract][Full Text] [Related]
4. [Prospective cohort study of fetal nuchal translucency in first-trimester and pregnancy outcome].
Tang HR; Zhang Y; Ru T; Li J; Yang L; Xu Y; Duan HL; Wang Y; Wang Y; Hu YL; Zhang Y; Zheng MM
Zhonghua Fu Chan Ke Za Zhi; 2020 Feb; 55(2):94-99. PubMed ID: 32146737
[No Abstract] [Full Text] [Related]
5. Contingent first-trimester screening for aneuploidies with cell-free DNA in a Danish clinical setting.
Miltoft CB; Rode L; Ekelund CK; Sundberg K; Kjaergaard S; Zingenberg H; Tabor A
Ultrasound Obstet Gynecol; 2018 Apr; 51(4):470-479. PubMed ID: 28640470
[TBL] [Abstract][Full Text] [Related]
6. What would be missed in the first trimester if nuchal translucency measurement is replaced by cell free DNA foetal aneuploidy screening?
Huang LY; Pan M; Han J; Zhen L; Yang X; Li DZ
J Obstet Gynaecol; 2018 May; 38(4):498-501. PubMed ID: 29433355
[TBL] [Abstract][Full Text] [Related]
7. Reexamining the optimal nuchal translucency cutoff for diagnostic testing in the cell-free DNA and microarray era: results from the Victorian Perinatal Record Linkage study.
Hui L; Pynaker C; Bonacquisto L; Lindquist A; Poulton A; Kluckow E; Hutchinson B; Norris F; Pertile MD; Gugasyan L; Kulkarni A; Harraway J; Howden A; McCoy R; da Silva Costa F; Menezes M; Palma-Dias R; Nisbet D; Martin N; Bethune M; Poulakis Z; Halliday J
Am J Obstet Gynecol; 2021 Nov; 225(5):527.e1-527.e12. PubMed ID: 33957116
[TBL] [Abstract][Full Text] [Related]
8. Prenatal screening for fetal aneuploidy in singleton pregnancies.
Chitayat D; Langlois S; Douglas Wilson R; ;
J Obstet Gynaecol Can; 2011 Jul; 33(7):736-750. PubMed ID: 21749752
[TBL] [Abstract][Full Text] [Related]
9. First-trimester screening for trisomies 18 and 13, triploidy and Turner syndrome by detailed early anomaly scan.
Wagner P; Sonek J; Hoopmann M; Abele H; Kagan KO
Ultrasound Obstet Gynecol; 2016 Oct; 48(4):446-451. PubMed ID: 26611869
[TBL] [Abstract][Full Text] [Related]
10. First-trimester risk assessment based on ultrasound and cell-free DNA vs combined screening: a randomized controlled trial.
Kagan KO; Sroka F; Sonek J; Abele H; Lüthgens K; Schmid M; Wagner P; Brucker S; Wallwiener D; Hoopmann M
Ultrasound Obstet Gynecol; 2018 Apr; 51(4):437-444. PubMed ID: 28925570
[TBL] [Abstract][Full Text] [Related]
11. Prenatal diagnosis of fetuses with increased nuchal translucency using an approach based on quantitative fluorescent polymerase chain reaction and genomic microarray.
Pan M; Han J; Zhen L; Yang X; Li R; Liao C; Li DZ
Eur J Obstet Gynecol Reprod Biol; 2016 Feb; 197():164-7. PubMed ID: 26771907
[TBL] [Abstract][Full Text] [Related]
12. Identification of submicroscopic chromosomal aberrations in fetuses with increased nuchal translucency and apparently normal karyotype.
Leung TY; Vogel I; Lau TK; Chong W; Hyett JA; Petersen OB; Choy KW
Ultrasound Obstet Gynecol; 2011 Sep; 38(3):314-9. PubMed ID: 21400624
[TBL] [Abstract][Full Text] [Related]
13. Increased nuchal translucency at 11-13 weeks' gestation and outcome in twin pregnancy.
Cimpoca B; Syngelaki A; Litwinska E; Muzaferovic A; Nicolaides KH
Ultrasound Obstet Gynecol; 2020 Mar; 55(3):318-325. PubMed ID: 31773823
[TBL] [Abstract][Full Text] [Related]
14. Screening for aneuploidies by maternal age, fetal nuchal translucency and maternal serum biochemistry at 11-13+6 gestational weeks.
Karadzov-Orlić N; Egić A; Filimonović D; Marinković M; Damnjanović-Pazin B; Milovanović Z; Joksić I; Branković S; Lukić R; Mandić V; Cerović N; Mojović D; Plamenac S; Stanković M; Maglić D; Mikovć Z
Srp Arh Celok Lek; 2012; 140(9-10):606-11. PubMed ID: 23289277
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness of 12-13-week scan for early diagnosis of fetal congenital anomalies in the cell-free DNA era.
Kenkhuis MJA; Bakker M; Bardi F; Fontanella F; Bakker MK; Fleurke-Rozema JH; Bilardo CM
Ultrasound Obstet Gynecol; 2018 Apr; 51(4):463-469. PubMed ID: 28397377
[TBL] [Abstract][Full Text] [Related]
16. Diagnosis of major heart defects by routine first-trimester ultrasound examination: association with increased nuchal translucency, tricuspid regurgitation and abnormal flow in ductus venosus.
Minnella GP; Crupano FM; Syngelaki A; Zidere V; Akolekar R; Nicolaides KH
Ultrasound Obstet Gynecol; 2020 May; 55(5):637-644. PubMed ID: 31875326
[TBL] [Abstract][Full Text] [Related]
17. Prenatal screening for and diagnosis of aneuploidy in twin pregnancies.
Audibert F; Gagnon A; ;
J Obstet Gynaecol Can; 2011 Jul; 33(7):754-67. PubMed ID: 21749753
[TBL] [Abstract][Full Text] [Related]
18. Is there still a role for nuchal translucency measurement in the changing paradigm of first trimester screening?
Bardi F; Bosschieter P; Verheij J; Go A; Haak M; Bekker M; Sikkel E; Coumans A; Pajkrt E; Bilardo C
Prenat Diagn; 2020 Jan; 40(2):197-205. PubMed ID: 31697852
[TBL] [Abstract][Full Text] [Related]
19. Factors associated with common and atypical chromosome abnormalities after positive combined first-trimester screening in Chinese women: a retrospective cohort study.
Mak A; Lee H; Poon CF; Kwok SL; Ma T; Chan KYK; Kan A; Tang M; Leung KY
BMC Pregnancy Childbirth; 2019 Feb; 19(1):55. PubMed ID: 30717698
[TBL] [Abstract][Full Text] [Related]
20. Clinical utility of non-invasive prenatal testing in pregnancies with ultrasound anomalies.
Beulen L; Faas BHW; Feenstra I; van Vugt JMG; Bekker MN
Ultrasound Obstet Gynecol; 2017 Jun; 49(6):721-728. PubMed ID: 27515011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
